Thousands of doctors are using it now.
Turkey claimed it cut down pneumonia.
Not confident in the reporting.
Interesting disclosure information in the study re authors:
Jayakrishna Ambati
Disclosure forms provided by the authors are available with the NEJM. JA is a co-founder of iVeena Holdings, iVeena Delivery Systems and Inflammasome Therapeutics, and has received consultancy fees from Allergan, Biogen, Boehringer Ingelheim, Immunovant, Janssen, Olix Pharmaceuticals, Retinal Solutions, and Saksin LifeSciences, all unrelated to this work.
JA is named as an inventor on a patent application filed by the University of Virginia relating to Covid-19 but unrelated to this work.
S Scott Sutton SSS has received research grants from Boehringer Ingelheim, Gilead Sciences, Portola Pharmac euticals, and United Therapeutics, all unrelated to this work
The other authors declare no competing interest
https://www.medrxiv.org/content/10.1101/2020.04.16.20065920v1.full.pdf+html
If you give the drug to those with the worst symptoms, you will get more deaths from that group than those who are not critical to begin with.